This kit uses RT-PCR to detect human mesenchymal-epithelial transition factor (MET) gene mutations in peripheral blood or formalin-fixed paraffin-embedded tissue (FFPE) samples. Targeted medication for non-small cell lung cancer (NSCLC). Confirmed mutation: recommended medications include savolitinib, gumetinib, etc.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
